Is the Renoprotective Effect of SGLT2 Inhibitors Due to Their Beneficial Effect on Hypomagnesemia?

Journal of Diabetes & Metabolism
doi 10.4172/2155-6156.1000772
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

SGLT2 Inhibitors

2020English

Is Cancer Incidence Modified by SGLT2 Inhibitors?

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus

Frontiers in Pharmacology
Pharmacology
2017English

Effect of Potassium and Hypomagnesemia on Insulin in the Bovine

Journal of Animal Science
Animal ScienceZoologyGeneticsMedicineFood Science
1976English

SGLT2 Inhibitors: Mind the Gap

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

No Direct Effect of SGLT2 Activity on Glucagon Secretion

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Class Effects of SGLT2 Inhibitors on Cardiorenal Outcomes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Hepatoprotective Effect of SGLT2 Inhibitor on Nonalcoholic Fatty Liver Disease

2020English

Effect of Salts and Organic Osmolytes Is Due to Conservative Forces

Asian Journal of Applied Chemistry Research
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy